$CURR announced that it has received the first tra
Post# of 103076
CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes (the "Notes" . Axiom Capital Management, Inc. acted as the sole placement agent in the transaction.
CURE may repay the obligations of the Notes in cash only, or the Notes may be converted upon election of the investor at a fixed price of $1.32 per share subject to certain adjustments.
https://finance.yahoo.com/news/cure-pharmaceu...00216.html